Previous Close | 27.69 |
Open | 27.62 |
Bid | 28.03 x 800 |
Ask | 29.31 x 800 |
Day's Range | 26.85 - 27.99 |
52 Week Range | 25.69 - 77.14 |
Volume | |
Avg. Volume | 568,918 |
Market Cap | 1.261B |
Beta (5Y Monthly) | 0.74 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.45 |
Earnings Date | Apr 30, 2024 - May 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 34.50 |
Subscribe to Yahoo Finance Plus to view Fair Value for OMCL
FORT WORTH, Texas, March 11, 2024--Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum
Investors are optimistic about Omnicell (OMCL) moving closer to achieving its vision of Autonomous Pharmacy.
In this article, we will be taking a look at the 20 most valuable digital health companies in the US. If you are not interested in reading about the global health market, head straight to the 5 Most Valuable Digital Health Companies In The US. As of the latest data, several digital health companies stand […]